<DOC>
	<DOCNO>NCT01466673</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety Ethinyl estradiol Norgestimate ( EE/NGM ) compare Ethinyl estradiol Desogestrel ( EE/DSG ) , treatment female participant mild moderate acne vulgaris ( pimple ) .</brief_summary>
	<brief_title>An Efficacy Safety Study Comparing Oral Contraceptive Containing Norgestimate Desogestrel Acne Treatment</brief_title>
	<detailed_description>This single-blind ( physician know name assign drug ) randomize ( study drug assign chance ) study compare effectiveness safety EE/NGM EE/DSG female participant use oral contraceptive mild moderate acne vulgaris . Tablets EE/NGM EE/DSG administer orally daily 6 month instruct visit evaluation Month 1 , 3 6 post-administration . The efficacy evaluate efficacy primarily total acne lesion count , record evaluation visit . Unused study medication collect drug accountability document . Participants ' safety monitor throughout study .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Desogestrel</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Norgestimate</mesh_term>
	<mesh_term>Norgestrel</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<criteria>Needs contraception family plan Mild moderate acne vulgaris Agrees take supply study drug treatment acne 6month treatment phase study Signs date inform consent participate study female participant age 18 45 year Pregnant nursing Known hypersensitivity ingredient currently significant adverse experience ethinyl estradiol , norgestimate desogestrel Any coexist medical condition take concomitant medication likely interfere safe administration ethinyl estradiol/norgestimate ethinyl estradiol/desogestrel , Investigator 's opinion Taking system retinoids , systemic antimicrobial , topical acne treatment within 6 month , 1 month , 2 week prior enrollment , respectively Taking investigational medication oral contraceptive within 30 day prior Screening</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Acne Vulgaris</keyword>
	<keyword>Ethinyl estradiol</keyword>
	<keyword>Norgestimate</keyword>
	<keyword>Desogestrel</keyword>
	<keyword>Tricilest</keyword>
	<keyword>Oilezz</keyword>
</DOC>